コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 target for potential drug therapies to treat muscle pain.
2 y systemic symptoms such as fever, bone, and muscle pain.
3 els of peripheral neuropathy to evaluate for muscle pain.
4 nd transient, mild lower-extremity edema and muscle pain.
5 ot appear to modulate acute exercise-induced muscle pain.
6 nd was free of muscle weakness, and bone and muscle pain.
7 y accepted as a causal mechanism for chronic muscle pain.
8 d fever (temperature >38.5 degrees C), 7 had muscle pain, 6 had sinusitis, and 6 had biopsy evidence
9 (1832 [25.4%]), fatigue (1361 [18.9%]), and muscle pain (942 [13.1%]) were the most commonly reporte
10 al underlying reasons for the comorbidity of muscle pain and altered sympathetic reflexes in disease
11 usible that this finding partly explains the muscle pain and exercise intolerance that many patients
12 development of alternative therapeutics for muscle pain and may be especially relevant to pain cause
14 Recovery occurred within 24 hrs, although muscle pain and weakness persisted for 2 months after st
15 wn statin-like lowering of LDL-C without the muscle pain and weakness responsible for discontinuation
16 the frequency of less-serious events such as muscle pain and weakness, which may affect 1% to 5% of p
18 A prevalent side effect of statin therapy is muscle pain, and yet the basic mechanism behind it remai
19 Many clinicians believe that statins cause muscle pain, but this has not been observed in clinical
20 le of the cAMP pathway in a model of chronic muscle pain by assessing associated behavioral changes a
23 e TA muscle were found during saline-induced muscle pain compared to the infusion of isotonic saline.
24 ns in blood flow/oxygenation and a number of muscle pain disorders are based in problems of periphera
26 nemius muscle strongly enhanced acid-induced muscle pain in mice that was abolished by genetic inacti
27 bubble gum for 6 min) increases masticatory muscle pain in patients, but not in asymptomatic control
28 males and seven females, with no history of muscle pain in the masticatory system participated in th
29 ), headache (in 25.1% and 31.9%, vs. 16.9%), muscle pain (in 22.3% and 26.9%, vs. 13.3%), feverishnes
30 t study was to determine if exercise-induced muscle pain is modulated by central neural mechanisms (i
31 ults support the suggestion that neuropathic muscle pain may be a greater clinical problem than gener
33 Evidence of muscle disease was indicated by muscle pain, muscle weakness and wasting, significant fa
34 -myo-neuropathy," characterized by joint and muscle pains, muscle fatigue, difficulty lifting, and ex
35 s, the placebo-corrected incidences of minor muscle pain, myopathy (with significant elevations in cr
37 fects of the statin-are myopathy (defined as muscle pain or weakness combined with large increases in
39 py may cause symptomatic adverse events (eg, muscle pain or weakness) in up to about 50-100 patients
42 with symptoms that include severe joint and muscle pain, rashes, and fever, as well as prolonged per
47 were neutropenia (38 [35%] of 110 patients), muscle pain (ten [9%]), rash (eight [7%]), cough, dyspno
52 hyperalgesia, and susceptibility to chronic muscle pain, which is unveiled by exposure to stress in
53 sh, fever episodes, arthralgia, and bone and muscle pain with cryopyrin-associated periodic syndromes
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。